Home › Stem Cell Cures

Stem Cell Cures

News Story
7/2/2013
Posted by Mark Reback
A stem cell patent held by a Wisconsin university foundation should be invalidated, according to a legal filing made Tuesday by two consumer advocate groups. Consumer Watchdog of Santa Monica and the New York-based Public Patent Foundation asked a federal appeals court to throw out the patent held by the Wisconsin Alumni Research Foundation on...
News Story
7/2/2013
Posted by Mark Reback
Two nonprofit groups are continuing their challenge to one of the Wisconsin Alumni Foundation's key embryonic stem cell patents by asking a federal appeals court to invalidate it. The Public Patent Foundation, based in New York, and Consumer Watchdog, Santa Monica, Calif., filed a brief Tuesday with the U.S. Court of Appeals for the Federal...
News Story
6/15/2013
Posted by Mark Reback
Pathway to market DNA screening that looks for mutations A new cancer test from San Diego-based Pathway Genomics will include results for two breast cancer genes formerly patented by Myriad Genetics. A Supreme Court decision on Thursday invalidated those and other patents on naturally occurring DNA. Pathway’s Hereditary Cancer DNA Insight...
News Story
2/13/2013
Posted by Mark Reback
Proposed Changes To Oversight Panel For California's Stem Cell Agency Garner Backing   Supporters of California's $3 billion stem cell research program are endorsing proposed changes to remove conflicts of interest and build public trust. While the agency has won praise for supporting research on cures for disease and injuries,...
News Story
1/30/2013
Posted by Mark Reback
The California agency's board is wrestling with recommendations for changes in its membership and its authority over the spending of its $3-billion endowment. Compromise, defined as the art of getting part of a loaf when the whole loaf is out of reach, comes in many forms. But surely the strangest of all is what comes of trying to compromise...
News Story
1/29/2013
Posted by Mark Reback
California's stem cell agency, which oversees $3 billion in research funds, has announced plans to address long-standing conflict of interest concerns involving its governing board. Under the new policy, tentatively approved last week, the 13 board members of the California Institute for Regenerative Medicine who represent institutions...
News Story
1/24/2013
Posted by Mark Reback
California’s US$3-billion stem-cell agency plans to make a few changes in response to an assessment last month by the Institute of Medicine, an outside panel of scientific experts. The governing board of the California Institute for Regenerative Medicine (CIRM) voted overwhelmingly to endorse a set of recommendations made by the chair of...
Blog Post
1/23/2013
Posted by John M. Simpson
It looks like the message is finally getting through to California's stem cell agency board.  The board has a fundamental conflict of interest -- 13 permanent slots are for representatives of the very institutions that receive 90 percent of the funding. Consumer Watchdog has been pointing out this flaw since the passage of Proposition 71...
News Story
12/7/2012
Posted by Mark Reback
The California Institute for Regenerative Medicine board should be restructured to shore up the integrity of its grant process, an Institute of Medicine report says. The board of California's stem cell funding agency is rife with conflicts of interest and should be restructured to improve the integrity of its grant-making process, according to...
News Release
12/6/2012
Posted by John M. Simpson
SANTA MONICA, CA – Consumer Watchdog Thursday welcomed a report from the prestigious Institute of Medicine (IOM) calling for sweeping reforms in governance at California’s stem cell agency and an end to the board’s built-in conflicts of interest.   The report said that “far too many board members represent...